Healthvista India Limited, the leading out-of-hospital healthcare provider in India with brand Portea (out-of-hospital healthcare services), has filed its Draft Red Herring Prospectus (“DRHP”) with market regulator Securities and Exchange Board of India (“SEBI”) for an initial public offering (“IPO”).
The Company plans to raise funds through an initial public offering (IPO) of equity shares (face value ₹ 1 each) comprising fresh issue aggregating up to ₹ 2,000 million, (the “Fresh Issue”) and an offer for sale up to 56,252,654 by Investor Selling Shareholders (the “Offer for Sale”)
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects: 1. Funding the working capital requirements of Material Subsidiary, namely Medybiz Pharma Private Limited; 2. Re-payment/ pre-payment of certain indebtedness availed by the Company; 3. Purchase of medical equipment; 4. Marketing and brand building activities; 5. Inorganic growth initiatives and general corporate purposes
The offer for sale comprises of equity shares up to 12,070,214 equity shares by Accel Growth III Holdings (Mauritius) Limited; up to 8,504,709 equity shares by Accel India III (Mauritius) Limited, up to 4,278,680 equity shares by Ventureast Life Fund III LLC Limited; up to 4,445,735 equity shares by MEMG CDC Ventures; up to 4,256,924 equity shares by Qualcomm Asia Pacific Pte Ltd, up to 4,229,951 equity shares by Accel India V (Mauritius) Limited and up to 3,984,752 equity shares by Sabre Partners Trust (“Investor Selling Shareholder”).
The Equity Shares offered through the Red Herring Prospectus are proposed to be listed on BSE and NSE.
SBI Capital Markets Limited, IIFL Securities Limited and JM Financial Limited are the Book Running Lead Managers (“BRLMs).
